Sermo/Fierce Pharma Survey of Oncologists Named Amgen and Novartis As Being The Top Contributing Drug Companies

This is another in the series of contributions of surveys and polls to provide actual MD comments and results on which drugs companies they feel are the biggest contributors to cancer with the best outcomes.  Amgen and Novartis are the top and there were others as well.  The actual report goes into more detail and you can read the entire report here.  Roche was right in there as well as #3.  BD   

In this new free report from Sermo, oncologists share which companies they believe are the top contributors to their field and what drugs they believe yield the best outcomes for their patients.
A total of 101 oncologists participated in the survey, a majority of which spend their time in clinical practice, treating between 50 and 150 patients per week.

http://clients.sermo.com/Article?art=0009&rs=fpct0009wsx&utm_source=fiercepharmacontent&utm_medium=website&utm_campaign=sermosurvey&utm_content=ctws_ssurvey_pharma_0009

Technorati Tags: FierceMarkets,Sermo,partnership,doctors,regulatory information,patients,cancer,surveys,healthcare,social networks,reimbursement